Here are three things to know:
1. Study authors used a Markov model analysis to evaluate data from the LDR Mobi-C investigational device exemption study. They featured 174 CDR patients and 79 ACDF patients in their analysis.
2. Assuming the operative candidate is 40-years-old and failed appropriate conservative care, the seven-year cost was $103,924 for ACDF and $105,637 for CDR.
3. CDR generated 5.33 quality-adjusted life years while ACDF generated 5.16 QALYs. The incremental cost-effectiveness ratio was $10,076/QALY in favor of CDR, which was less than the willingness-to-pay threshold of $50,000/QALY.
More articles on spine:
‘Medical cowboy’ & neurosurgeon named to Oklahoma research foundation board of directors
10 spine surgeon leaders to know
The best practices for improving time management as a spine surgeon
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
